Sign in
4

Changes in Ownership

PLIANT THERAPEUTICS, INC. Filed Acc 0000899243-21-000219

Chief Business Officer acquired 3,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hull Hans Chief Business Officer 2020-12-30 Option exercise +3,500 $2.08 $7,280 120,746 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Hull Hans Chief Business Officer 2020-12-30 Option exercise · Stock Option (right to buy) −3,500 17,479 D: show line 2 in the form
Loading xslF345X03/doc4.xml…